Paper6283496
Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
Bataille D and 6 others. Peptides, 1981. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities. Papers, record 6283496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6283496
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Hormones | Major topic |
| Glucagon-Like Peptides | Major topic |
| Ileum | Major topic |
| Jejunum | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Cyclic AMP | |
| Gastric Fundus | |
| Glucagon | |
| Oxyntomodulin | |
| Peptide Fragments | |
| Rats | |
| Swine |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40969875 | Ultrastable Insulin-Glucagon Fusion Protein Exploits an Endogenous Hepatic Switch to Mitigate Hypoglycemic Risk. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40969875 | PubMed |
| 36932176 | Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/36932176 | PubMed |
| 34093449 | Proglucagon-Derived Peptides as Therapeutics. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34093449 | PubMed |
| 33668627 | Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity. | Nutrients | 2021 | https://conductscience.org/library/papers/33668627 | PubMed |
| 31671667 | Methods and Guidelines for Measurement of Glucagon in Plasma. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31671667 | PubMed |
| 30662430 | The Regulation of Peripheral Metabolism by Gut-Derived Hormones. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30662430 | PubMed |
| 27856285 | Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. | Exp Neurol | 2017 | https://conductscience.org/library/papers/27856285 | PubMed |
| 27713245 | Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713245 | PubMed |
| 25217372 | Can Bayliss and Starling gut hormones cure a worldwide pandemic? | J Physiol | 2014 | https://conductscience.org/library/papers/25217372 | PubMed |
| 25061485 | The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes. | Prz Gastroenterol | 2014 | https://conductscience.org/library/papers/25061485 | PubMed |
| 24749050 | Action and therapeutic potential of oxyntomodulin. | Mol Metab | 2014 | https://conductscience.org/library/papers/24749050 | PubMed |
| 24222092 | The role of gastrointestinal hormones in hepatic lipid metabolism. | Semin Liver Dis | 2013 | https://conductscience.org/library/papers/24222092 | PubMed |
| 23248172 | Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. | Diabetes | 2013 | https://conductscience.org/library/papers/23248172 | PubMed |
| 23019069 | Unraveling oxyntomodulin, GLP1's enigmatic brother. | J Endocrinol | 2012 | https://conductscience.org/library/papers/23019069 | PubMed |
| 22899902 | Obesity and appetite control. | Exp Diabetes Res | 2012 | https://conductscience.org/library/papers/22899902 | PubMed |
| 22434197 | Bariatric surgery evolution from the malabsorptive to the hormonal era. | Obes Surg | 2012 | https://conductscience.org/library/papers/22434197 | PubMed |
| 11839727 | Gut adaptation and the glucagon-like peptides. | Gut | 2002 | https://conductscience.org/library/papers/11839727 | PubMed |
| 9741838 | GLP-1 receptors in golden Syrian hamster islets: identification and functional characterization. | Endocrine | 1998 | https://conductscience.org/library/papers/9741838 | PubMed |
| 6429938 | Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study. | Virchows Arch A Pathol Anat Histopathol | 1984 | https://conductscience.org/library/papers/6429938 | PubMed |
| 6207142 | Immunohistochemical studies on glucagon, glicentin and pancreatic polypeptide in human stomach: normal and pathological conditions. | Histochem J | 1984 | https://conductscience.org/library/papers/6207142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6283496
GET https://conductscience.org/api/papers/v1/6283496/cited_by?page=2